Phase I/II trial of single-fraction high-dose-rate brachytherapy–boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate
2017 ◽
Vol 6
(2)
◽
pp. 269-274
◽
2009 ◽
Vol 75
(3)
◽
pp. S340
2010 ◽
Vol 76
(1)
◽
pp. 269-276
◽
2014 ◽
Vol 111
(1)
◽
pp. 126-131
◽